Prospective study of surgical decision-making processes for contralateral prophylactic mastectomy in women with breast cancer

Annals of Surgery

Volumn 263, Issue 1, 2016, Pages 178-183

  Parker, Patricia A ^a   Peterson, Susan K ^a   Bedrosian, Isabelle ^b   Crosby, Melissa A ^b   Shen, Yu ^b   Black, Dalliah M ^b   Babiera, Gildy ^b   Kuerer, Henry M ^b   Ying, Jun ^b   Dong, Wenli ^b   Cantor, Scott B ^b   Brewster, Abenaa M ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Breast cancer; Contralateral prophylactic mastectomy; Decision making; Surgical

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ADULT; AGE; AGED; AMBULATORY CARE; ARTICLE; ATTITUDE TO HEALTH; BODY IMAGE; BREAST CANCER; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; DISEASE SEVERITY; EDUCATIONAL STATUS; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; ETHNICITY; FAMILY HISTORY; FEMALE; FIRST DEGREE RELATIVE; HETEROZYGOTE; HUMAN; HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 POSITIVE BREAST CANCER; IMPACT OF EVENTS SCALE; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MASTECTOMY; PATIENT DECISION MAKING; PATIENT EDUCATION; PATIENT PARTICIPATION; PATIENT WORRY; PRIORITY JOURNAL; PROGESTERONE RECEPTOR POSITIVE BREAST CANCER; PROPHYLACTIC MASTECTOMY; PROPHYLACTIC SURGICAL PROCEDURE; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; SEGMENTAL MASTECTOMY; SOCIAL PSYCHOLOGY; SURGICAL TECHNIQUE; UNILATERAL MASTECTOMY; BREAST NEOPLASMS; DECISION MAKING; MIDDLE AGED; PSYCHOLOGY; YOUNG ADULT;

ADULT; AGED; BREAST NEOPLASMS; DECISION MAKING; FEMALE; HUMANS; MASTECTOMY; MIDDLE AGED; PROPHYLACTIC SURGICAL PROCEDURES; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84953840470     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000001216     Document Type: Article

References (51)

1. Yao K, Stewart AK, Winchester DJ, et al. Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the National Cancer Data Base, 1998-2007. Ann Surg Oncol. 2010;17:2554-2562.
2. Tuttle T, Habermann E, Abraham A, et al. Contralateral prophylactic mastectomy for patients with unilateral breast cancer. Expert Rev Anticancer Ther. 2007;7:1117-1122.
3. Tuttle TM, Habermann EB, Grund EH, et al. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol. 2007;25:5203-5209.
4. Tuttle TM, Jarosek S, Habermann EB, et al. Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. J Clin Oncol. 2009;27:1362-1367.
5. Dragun AE, Pan J, Riley EC, et al. Increasing use of elective mastectomy and contralateral prophylactic surgery among breast conservation candidates: a 14-year report from a comprehensive cancer center. Am J Clin Oncol. 2013;36:375-380.
6. Lostumbo L, Carbine N, Wallace J, et al. Prophylactic mastectomy for the prevention of breast cancer. Cochrane Database Syst Rev. 2004;11:CD002748.
7. Bedrosian I, Hu CY, Chang GJ. Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients. J Natl Cancer Inst. 2010;102:401-409.
8. Yao K, Winchester DJ, Czechura T, et al. Contralateral prophylactic mastectomy and survival: report from the National Cancer Data Base; 1998-2002. Breast Cancer Res Treat. 2013;142:465-476.
9. Chung A, Huynh K, Lawrence C, et al. Comparison of patient characteristics and outcomes of contralateral prophylactic mastectomy and unilateral total mastectomy in breast cancer patients. Ann Surg Oncol. 2012;19:2600-2606.
10. Kollias J, Ellis IO, Elston CW, et al. Clinical and histological predictors of contralateral breast cancer. Eur J Surg Oncol. 1999;25:584-589.
11. Robbins GF, Berg JW. Bilateral primary breast cancer; a prospective clinicopathological study. Cancer. 1964;17:1501-1527.
12. Healey EA, Cook EF, Orav EJ, et al. Contralateral breast cancer: clinical characteristics and impact on prognosis. J Clin Oncol. 1993;11:1545-1552.
13. Rosen PP, Groshen S, Kinne DW, et al. Contralateral breast carcinoma: an assessment of risk and prognosis in stage I (T1N0M0) and stage II (T1N1M0) patients with 20-year follow-up. Surgery. 1989;106:904-910.
14. Rosenberg SM, Partridge AH. Contralateral prophylactic mastectomy: an opportunity for shared decision making. JAMA Surg. 2014;149:589-590.
15. Graves KD, Peshkin BN, Halbert CH, et al. Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivors. Breast Cancer Res Treat. 2007;104:321-329.
16. Rosenberg SM, Tracy MS, Meyer ME, et al. Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: a cross-sectional survey. Ann Intern Med. 2013;159:373-381.
17. Tercyak KP, Peshkin BN, Brogan BM, et al. Quality of life after contralateral prophylactic mastectomy in newly diagnosed high-risk breast cancer patients who underwent BRCA1 (2 gene testing. J Clin Oncol. 2007;25:285-291.
18. Montgomery LL, Tran KN, Heelan MC, et al. Issues of regret in women with contralateral prophylactic mastectomies. Ann Surg Oncol. 1999;6:546-552.
19. Frost MH, Hoskin TL, Hartmann LC, et al. Contralateral prophylactic mastectomy: long-term consistency of satisfaction and adverse effects and the significance of informed decision-making, quality of life, and personality traits. Ann Surg Oncol. 2011;18:3110-3116.
20. Fagerlin A, Lakhani I, Lantz PM, et al. An informed decision? Breast cancer patients and their knowledge about treatment. Patient Educ Couns. 2006;64:303-312.
21. Fox SA, Heritage J, Stockdale SE, et al. Cancer screening adherence: does physicianpatient communication matter? Patient Educ Couns. 2009;75:178-184.
22. Chen JY, Tao ML, Tisnado D, et al. Impact of physician-patient discussions on patient satisfaction. Med Care. 2008;46:1157-1162.
23. Frost MH, Slezak JM, Tran NV, et al. Satisfaction after contralateral prophylactic mastectomy: the significance of mastectomy type, reconstructive complications, and body appearance. J Clin Oncol. 2005;23:7849-7856.
24. Gershenwald JE, Hunt KK, Kroll SS, et al. Synchronous elective contralateral mastectomy and immediate bilateral breast reconstruction in women with early-stage breast cancer. Ann Surg Oncol. 1998;5:529-538.
25. Schwartz MD. Contralateral prophylactic mastectomy: efficacy, satisfaction, and regret. J Clin Oncol. 2005;23:7777-7779.
26. Nekhlyudov L, Bower M, Herrinton LJ, et al. Women's decision-making roles regarding contralateral prophylactic mastectomy. J Natl Cancer Inst Monogr. 2005;35:55-60.
27. O'Connor AM, Tugwell P, Wells GA, et al. A decision aid for women considering hormone therapy after menopause: decision support framework and evaluation. Patient Educ Couns. 1998;33:267-279.
28. O'Connor AM, Jacobsen MJ, Stacey D. An evidence-based approach to managing women's decisional conflict. J Obstet Gynecol Neonatal Nurs. 2002;31:570-581.
29. Giuliano AE, Boolbol S, Degnim A, et al. Society of Surgical Oncology: position statement on prophylactic mastectomy. Approved by the Society of Surgical Oncology Executive Council, March 2007. Ann Surg Oncol. 2007;14:2425-2427.
30. Horowitz M, Wilner N, Alvarez W. Impact of Event Scale: a measure of subjective stress. Psychosom Med. 1979;41:209-218.
31. Mishel MH. The measurement of uncertainty in illness. Nurs Res. 1981;30:258-263.
32. Mishel MH. Parents' perception of uncertainty concerning their hospitalized child. Nurs Res. 1983;32:324-330.
33. Mishel MH, Hostetter T, King B, et al. Predictors of psychosocial adjustment in patients newly diagnosed with gynecological cancer. Cancer Nurs. 1984;7:291-299.
34. Mishel MH. Adjusting the fit: development of uncertainty scales for specific clinical populations. West J Nurs Res. 1983;5:355-370.
35. Lerman C, Trock B, Rimer BK, et al. Psychological side effects of breast cancer screening. Health Psychol. 1991;10:259-267.
36. McCaul KD, Schroeder DM, Reid PA. Breast cancer worry and screening: some prospective data. Health Psychol. 1996;15:430-433.
37. Mehta SS, Lubeck DP, Pasta DJ, et al. Fear of cancer recurrence in patients undergoing definitive treatment for prostate cancer: results from CaPSURE. J Urol. 2003;170:1931-1933.
38. Hart SL, Latini DM, Cowan JE, et al. Fear of recurrence, treatment satisfaction, and quality of life after radical prostatectomy for prostate cancer. Support Care Cancer. 2008;16:161-169.
39. Borgen PI, Hill AD, Tran KN, et al. Patient regrets after bilateral prophylactic mastectomy. Ann Surg Oncol. 1998;5:603-606.
40. Greenberg DB, Kornblith AB, Herndon JE, et al. Quality of life for adult leukemia survivors treated on clinical trials of Cancer and Leukemia Group B during the period 1971-1988: predictors for later psychologic distress. Cancer. 1997;80:1936-1944.
41. Street RL Jr, Voigt B, Geyer C Jr, et al. Increasing patient involvement in choosing treatment for early breast cancer. Cancer. 1995;76:2275-2285.
42. Green MJ, Peterson SK, Baker MW, et al. Use of an educational computer program before genetic counseling for breast cancer susceptibility: effects on duration and content of counseling sessions. Genet Med. 2005;7:221-229.
43. Green MJ, Peterson SK, Baker MW, et al. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial. JAMA. 2004;292:442-452.
44. Bowen DJ, Patenaude AF, Vernon SW. Psychosocial issues in cancer genetics: from the laboratory to the public. Cancer Epidemiol Biomarkers Prev. 1999;8:326-328.
45. Cash TF, Grasso K. The norms and stability of new measures of the multidimensional body image construct. Body Image. 2005;2:199-203.
46. Stacey D, Legare F, Col NF, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2014;1:CD001431.
47. Soran A, Ibrahim A, Kanbour M, et al. Decision making and factors influencing long-term satisfaction with prophylactic mastectomy in women with breast cancer. Am J Clin Oncol. 2015;38:179-183.
48. King TA, Sakr R, Patil S, et al. Clinical management factors contribute to the decision for contralateral prophylactic mastectomy. J Clin Oncol. 2011;29:2158-2164.
49. Howard-McNatt M, Schroll RW, Hurt GJ, et al. Contralateral prophylactic mastectomy in breast cancer patients who test negative for BRCA mutations. Am J Surg. 2011;202:298-302.
50. Tuttle TM, Abbott A, Arrington A, et al. The increasing use of prophylactic mastectomy in the prevention of breast cancer. Curr Oncol Rep. 2010;12:16-21.
51. Jones NB, Wilson J, Kotur L, et al. Contralateral prophylactic mastectomy for unilateral breast cancer: an increasing trend at a single institution. Ann Surg Oncol. 2009;16:2691-2696.